The cluster is small and stale (Q3 2026 data disclosed with 45-day lag). Monitor next 13F filing for continuation or reversal of this modest accumulation trend.
RLAY drugs
RLAY drug pipeline →How the stock moved after the report
NEUTRAL VIEWSTOCK ABOVE ENTRY AT T+5- T+0 · Nov 3 $17.44entry
- T+1 · 13d ago +3.38%α +1.73% · $18.03
- T+5 · 7d ago +14.33%α +14.92% · $19.94
- T+9 · todayOpen
- T+20 · in 15d Pending
- T+60 · in 3mo Pending
How similar events traded
Executive Summary
Three asset managers increased their RLAY positions in Q3 2026, adding a net $1.9M in holdings, while one manager trimmed by $247K. The cluster is small in dollar terms and lacks insider buying corroboration, suggesting limited conviction.
Key Financial Metrics
Institutional Positions
Net institutional flow: $1.9M
▲ Buyers (3)
| Institution | Action | Change | Position Value | Value Δ |
|---|---|---|---|---|
| Alps Advisors | ADD | +31.7% | $5.2M | $1.1M |
| Creative Planning | ADD | +27.9% | $2.6M | $499.0K |
| Principal Financial Group | DOUBLED | +152.3% | $476.0K | $281.0K |
▼ Sellers (1)
| Institution | Action | Change | Prev Value | Value Δ |
|---|---|---|---|---|
| Strs Ohio | TRIM | -69.5% | $350.0K | -$247.0K |
Key Facts
- 3 institutional buyers added $1.9M in net new holdings during Q3 2026
- 1 institutional seller trimmed $247K
- Largest buyer was Alps Advisors (ADD, +$1.1M), followed by Creative Planning (ADD, +$499K) and Principal Financial Group (DOUBLED, +$281K)
- Strs Ohio trimmed 69.5% of its position, reducing by $247K
- Insider activity is divergent (score 4/100) with no open-market insider buying
Financial Impact
Net institutional buying of $1.9M, representing about 0.04% of RLAY's $4.3B market cap
Risk Factors
- 13F data is 45+ days stale; positions may have been unwound since quarter-end
- No insider buying corroboration weakens the signal
- All buyers are asset managers, not activist or event-driven funds, limiting conviction
Market Snapshot
Investment Themes
Documents Analyzed
This report is based on 1 institutional 13F filing from SEC EDGAR.
| Document | Accession Number |
|---|---|
| INST-CLUSTER Data (Synthetic) | inst-cluster-RLAY-2026-Q3 |
Track record
21 reports on RLAY
6 of 10 bullish or bearish reports moved the stock their way by T+60. Best: +65.12% at T+60 after the May 19, 2026 report. 8 of 11 went positive at some point.
Filters
- Nov 16, 2026today SC 13G/A Neutral 3/10 Entry $17.50 settles Feb 16
- Nov 16, 2026today SC 13G Neutral 4/10 Entry $17.68 settles Feb 12
- Nov 4, 202612d ago 8-K Neutral 4/10 No price data
- Nov 4, 202612d ago Press Release Neutral 4/10 Entry $17.00 settles Feb 3
- Nov 3, 202613d ago Institutional Cluster Neutral 2/10 Viewing Entry $17.44 settles Feb 1
- Oct 7, 20265w ago 144 Neutral 2/10 Entry $17.41 settles Jan 5
- Oct 6, 20265w ago 144 Neutral 3/10 Entry $17.95 settles Jan 4
- Sep 9, 20269w ago Insider Cluster Neutral 4/10 Entry $18.89 settles Dec 4
- Aug 28, 202611w ago Insider Cluster Bearish 6/10 Entry $18.77 settles Nov 23
- Aug 18, 202612w ago Insider Cluster Bearish 5/10 Entry $20.74 to $19.72 ▲ +4.92% +4.09% vs SPY
US Market Status
Subscribe to SecBot
Get Real-Time SEC Filing Intelligence
Comprehensive SEC filing analysis delivered the moment filings hit EDGAR. Sentiment scoring, impact analysis, and actionable insights for every material event.
Create a free account Live analysis, Telegram alerts, watchlists and the MCP server for subscribers